Abstract:Background and purpose:Intensity-modulated radiation therapy(IMRT) enables the delivery of higher radiation dose to the primary disease and neck metastases while sparing the organs/tissues at risk(OARs) thereby IMRT combined with chemotherapy enhancing the therapeutic ratio.How to further improve the efficacy became a common topic of the oncologists.Different stages of nasopharyngeal carcinoma(NPC) have different efficacy.The subgroups in the same stage whether have different efficacy still remain to be studied.This study retrospectively analyzed the outcome of clinical stage Ⅲ NPC patients treated with IMRT after induction chemotherapy with or without adjuvant chemotherapy.Methods:From Nov.2003 to Jun.2006,133 patients with untreated stage Ⅲ NPC were analyzed retrospectively.According to the AJCC 2002 staging system: 7(5.3%) patients were T3N0,39(29.3%) patients were T3N1,48(36.1%) patients were T2N2,39(29.3%) patients were T3N2.All the patients received IMRT.One hundred and twenty-four patients received induction chemotherapy.Twenty-four patients received concurrent chemotherapy.Thirty-three patients received adjuvant chemotherapy.Results:The 5-year local-regional free survival(LRFS),distant metastasis-free survival(DMFS),disease-free survival(DFS) and overall survival(OS) were 90.9%,89.9%,82.5%,and 83.4%.The 5-year LRFS,DMFS,DFS and OS of patients with T2,T3 disease were 93.1% vs 89.4%(χ2=0.407,P=0.524),91.2% vs 89.3%(χ2=0.152,P=0.697),86.5% vs 80.0%(χ2=0.899,P=0.343),81.1% vs 84.7%(χ2=0.311,P=0.577).The 5-year LRFS,DMFS,DFS and OS of patients with N0-1,N2 disease were 91.1% vs 90.9%(χ2=0.007,P=0.933),97.8% vs 85.8%(χ2=4.69,P=0.030),88.9% vs 79.2%(χ2=1.746,P=0.1836),93.5% vs 78.1%(χ2=5.052,P=0.025).Adjuvant chemotherapy provided no significant benefit to IMRT in stage Ⅲ NPC,but was responsible for higher rates of grade 3 or 4 toxicities(48% vs 27.6%,P<0.005).Conclusion:IMRT combined with chemotherapy is an effective treatment for patients diagnosed with stage Ⅲ NPC.Patients with N0-1 disease have a better OS and DMFS than patients with N2 disease.Further improving the effect of stage Ⅲ NPC still need to explore the significance of adjuvant chemotherapy and look for more effective chemotherapy drugs,targeted drugs and more reasonable combined treatments.

Intensity-modulated radiotherapy for 69 locally recurrent nasopharyngeal carcinoma cases:analysis of efficacy and prognostic factors

Preliminary Results of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma with Intensity Modulated Radiotherapy

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma

Effect analysis of 847 nasopharyngeal carcinoma cases treated with intensity modulated radiation: Experience and suggestions

The Primary Result of Intensity Modulated Radiation Therapy for Nasopharyngeal(Report of 230 Cases)

Long-term Efficacy and Adverse Effects of Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

Local Regression and Control of T1-2 Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.

Preliminary Results of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy: a Retrospective Study of 364 Patients

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

Sequential Chemotherapy and Intensity-Modulated Radiation Therapy in the Management of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience of 370 Consecutive Cases

Ten-Year Results of Intensity-Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma: New Insight into the Value of Concurrent Chemotherapy

Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study

Efficacy of clinical stage Ⅲ nasopharyngeal carcinoma treated by intensity-modulated radiation therapy combined with chemotherapy

Preliminary Research on Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy

Failure patterns and individualized treatment plans of reirradiation for inoperable locally recurrent nasopharyngeal carcinoma

[Concurrent Control Study of Different Radiotherapy for Primary Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy Versus Conventional Radiotherapy].

Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy

Long-term efficacy of hyperfractionated intracavitary brachytherapy on 69 patients with locally recurrent nasopharyngeal carcinoma